Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.96 CAD | +10.61% | +9.70% | +2.86% |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company has insufficient levels of profitability.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.86% | 709M | C | ||
+14.31% | 81.04B | C+ | ||
-30.46% | 68.93B | B- | ||
+9.93% | 29.59B | C+ | ||
+0.04% | 17.24B | A- | ||
-11.30% | 16.99B | B | ||
-1.26% | 15.12B | A- | ||
+2.64% | 13.09B | B- | ||
+62.55% | 12B | C+ | ||
+29.68% | 11.91B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- WELL Stock
- Ratings WELL Health Technologies Corp.